Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Take LSD, stay out of prison? Huge study links psychedelic use to reduced recidivism

by Eric W. Dolan
January 8, 2014
in Psychopharmacology
Share on TwitterShare on Facebook

Psilocybe mushroomsA study of more than 25,000 people under community corrections supervision suggests the use of psychedelic drugs like LSD can keep people out of prison.

The research is the first in 40 years to examine whether drugs like LSD and “magic” mushrooms can help reform criminals.

“Our results provide a notable exception to the robust positive link between substance use and criminal behavior,” the researchers from the University of Alabama at Birmingham and Johns Hopkins University School of Medicine wrote in their study, which was published in the January issue of the Journal of Psychopharmacology.

“They add to both the older and emerging body of data indicating beneficial effects of hallucinogen interventions, and run counter to the legal classification as well as popular perception of hallucinogens as categorically harmful substances with no therapeutic potential.”

Psychedelic substances piqued the interest of researchers beginning in the 1950s. Studies indicated that the drugs could be combined with psychotherapy to treat a number of conditions, including alcoholism and drug addiction.

But scientific investigations into the therapeutic potential of LSD, psilocybin, mescaline, and other psychedelic drugs ground to a halt in the 1970s, when they were outlawed by the federal Controlled Substances Act.

“Offenders may be especially likely to benefit from hallucinogen treatment because involvement in the criminal justice system often results from drug-seeking behavior and impulsive conduct exacerbated by compulsive substance use,” the researchers explained in the study.

From 2002 to 2007, the researchers collected data on 25,622 individuals under community corrections supervision in Treatment Accountability for Safer Communities (TASC), a program for individuals with a history of drug abuse.

Google News Preferences Add PsyPost to your preferred sources

Only about 1 percent of those in the program were diagnosed with a hallucinogen use disorder. Cannabis use disorders, cocaine use disorders, and alcohol use disorders were the most common diagnoses in the group.

The researchers found those diagnosed with a hallucinogen use disorder were less likely to fail the TASC program compared to those without a hallucinogen use disorder. That means those with a hallucinogen use disorder were less likely to violate TASC rules or other legal requirements, less likely to fail to appear in court, and less likely to be incarcerated.

The study controlled for a large number of potentially confounding factors, including race, employment, marital status, age, criminal history, drug abuse history, gender, educational attainment, and more.

“The current findings should not at all be interpreted as advocating for recreational hallucinogen use. Nevertheless, they demonstrate that, in a real-world, substance-related intervention setting, hallucinogen use is associated with a lower probability of poor outcome,” the researchers wrote.

“We believe this calls for the continued scientific investigation of this unique class of substances.”

The study was authored by Peter S. Hendricks, C. Brendan Clark, Matthew W. Johnson, Kevin R. Fontaine, and Karen L. Cropsey.

Previous Post

The ironic (and surprising) effects of weight stigma

Next Post

When charitable acts are ‘tainted’ by personal gain

RELATED

Democrats dislike Republicans more than Republicans dislike Democrats, studies find
Ayahuasca

A single dose of DMT reverses depression-like symptoms in mice by repairing brain circuitry

March 8, 2026
Stimulant medications normalize brain structure in children with ADHD, study suggests
ADHD Research News

Long-term ADHD medication use does not appear to permanently alter the developing brain

March 5, 2026
Hemp-derived cannabigerol shows promise in reducing anxiety — and maybe even improving memory
Alcohol

Using cannabis to cut back on alcohol? Your working memory might dictate if it works

March 5, 2026
New psychology research flips the script on happiness and self-control
Cannabis

Exploring the motivations for cannabis use during sex

March 4, 2026
Chocolate lovers’ brains: How familiarity influences reward processing
Cognitive Science

A single dose of cocoa flavanols improves cognitive performance during aerobic exercise

March 4, 2026
Scientists discover psychedelic drug 5-MeO-DMT induces a state of “paradoxical wake”
Ayahuasca

Scientists discover psychedelic drug 5-MeO-DMT induces a state of “paradoxical wake”

March 4, 2026
New research: AI models tend to reflect the political ideologies of their creators
Neuroimaging

Psilocybin produces different behavioral and brain-altering effects depending on the dose

February 26, 2026
Consumption of gluten harms the hypothalamus region of the brain in male mice and may lead to obesity, study finds
Ketamine

Ketamine blocks the short-term anxiety and social withdrawal linked to adolescent social defeat

February 25, 2026

STAY CONNECTED

LATEST

Therapists test an AI dating simulator to help chronically single men practice romantic skills

Women with tattoos feel more attractive but experience the same body anxieties in the bedroom

Misophonia is strongly linked to a higher risk of mental health and auditory disorders

Brain scans reveal the unique brain structures linked to frequent lucid dreaming

Black Lives Matter protests sparked a short-term conservative backlash but ultimately shifted the 2020 election towards Democrats

Massive global study links the habit of forgiving others to better overall well-being

Neuroscientists have pinpointed a potential biological signature for psychopathy

Supportive relationships are linked to positive personality changes

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc